Semaglutide and Tirzepatide are powerful GLP-1 medications helping men lose weight effectively. But which one suits you best? At Heyday, we evaluate your body’s needs, history, and goals to guide you toward the right option.
We don’t believe in one-size-fits-all. Our expert providers assess your goals, body type, and medical history to match you with the most effective treatment.
Understanding your blood sugar levels and insulin response helps determine the best treatment.
Your past challenges and successes shape a personalized medication plan.
Muscle vs. fat ratio matters when choosing between Semaglutide and Tirzepatide.
Our experts analyze how your body reacts to GLP-1 or dual-agonist therapies for best results.
Semaglutide is a GLP-1 receptor agonist known under brand names like Ozempic and Wegovy. Originally for type 2 diabetes, it’s now a game-changer in obesity management.
Semaglutide helps men lose weight by reducing appetite and supporting steady fat loss of 1–2 pounds per week. It’s a once-weekly injection that also improves blood sugar control.
Tirzepatide is a newer medication working on both GLP-1 and GIP receptors, which may offer faster fat reduction and enhanced insulin sensitivity.
Tirzepatide offers enhanced fat loss through its dual action on GLP-1 and GIP receptors. Men often experience faster results, improved insulin sensitivity, and steady weekly progress. Dual-action (GLP-1 + GIP)
Hormone optimization, weight loss, and longevity treatments powered by at-home labs and expert-guided telehealth.
Whether you’re leaning toward Semaglutide or interested in Tirzepatide’s dual-action advantage, Disc Doctor 911 is here to support your transformation.
Yes, when prescribed by professionals, it’s safe and effective for male weight loss.
Yes, with medical supervision, transitioning is possible.
Most men see changes within 2–4 weeks of starting treatment.
